Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

TT-012

TT-012 has anti-tumor activity, selectively binds dynamic MITF and disrupts the dimer formation and DNA binding of the latter. TT-012 can inhibit the transcription of MITF in B16F10 melanoma cells. TT-012 inhibited the growth and metastasis of MITF melanoma cells in animal models. TT-012 is less cytotoxic to liver and immune cells.

Product Specifications

CAS Number

1164471-33-3

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

349.34

Molecular Formula

C19H15N3O4

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human E3 ubiquitin-protein ligase RNF138, RNF138 ELISA KIT
ELI-52543h 96 Tests

Human E3 ubiquitin-protein ligase RNF138, RNF138 ELISA KIT

Sign In for Pricing
View Details
CTAGE1, ID (CTAGE1, CTAGE2, Protein cTAGE-2, Cancer/testis antigen 21.2) (MaxLight 650) discontinued
034318-ML650 100 µL

CTAGE1, ID (CTAGE1, CTAGE2, Protein cTAGE-2, Cancer/testis antigen 21.2) (MaxLight 650) discontinued

Sign In for Pricing
View Details
CD39, Human (Q96A, N99A, E143A, R147E, HEK293, His)
HY-P704470 100 µg

CD39, Human (Q96A, N99A, E143A, R147E, HEK293, His)

Sign In for Pricing
View Details
Carbon dioxide reduction factor
T30743 25 mg

Carbon dioxide reduction factor

Sign In for Pricing
View Details
PMT-O9-1A
orb2695524-01 25 mg

PMT-O9-1A

Sign In for Pricing
View Details
PMT-O9-1A
orb2695524-02 50 mg

PMT-O9-1A

Sign In for Pricing
View Details